Become Affiliate

PepFlow

Download

The LH Mimic

hCG

hCG is human chorionic gonadotropin, a placental glycoprotein hormone that activates the LH/CG receptor.

Fertility hormones
TierA
EvidenceStrong
SafetyWell-Studied
FDA statusApproved
Last reviewed October 25, 2026 35 citations How to read these labels

What is hCG?

hCG is human chorionic gonadotropin, a placental glycoprotein hormone that activates the LH/CG receptor.[1][2][3]

Clinically, hCG is used in fertility and reproductive-endocrine contexts such as ovulation triggering and selected hypogonadotropic hypogonadism situations, depending on product label.[1][2][3]

In men, hCG can stimulate Leydig-cell testosterone production, which is why it appears in fertility-preservation and androgen-axis discussions. That does not make it a weight-loss or bodybuilding peptide.[1][2][3]

What hCG is investigated for

hCG evidence is grouped by practical use case and injectable, sublingual, and intrauterine route context. Each use case separates confidence, human evidence, animal or mechanistic support, and the practical takeaway.

Ovulation trigger and assisted reproduction

Injectable

82%Strong

Ovulation triggering has the highest-confidence hCG evidence and is separate from unsupported weight-loss claims.[1][5][6]

Human evidence

Pregnyl labeling and gonadotropin literature support hCG for ovulation induction and assisted reproduction contexts.[1][5][6]

Animal / mechanistic evidence

The mechanism is LH-receptor activation to trigger final follicular maturation and ovulation.[1][5][6]

Male hypogonadotropic hypogonadism and fertility

Injectable

70%Moderate

Male reproductive-axis support is human-studied and condition-specific.[1][2][3][10]

Human evidence

Human reviews and label context support hCG in male hypogonadotropic hypogonadism and selected infertility settings.[1][2][3][10]

Animal / mechanistic evidence

The rationale is LH-like Leydig-cell stimulation to support testosterone and spermatogenesis pathways.[1][2][3][10]

Cryptorchidism and delayed puberty in boys

Injectable

66%Moderate

Pediatric use is a distinct clinician-managed label indication, not a general wellness use.[1][5]

Human evidence

Pregnyl labeling includes selected pediatric uses such as prepubertal cryptorchidism not due to obstruction and selected hypogonadotropic hypogonadism contexts.[1][5]

Animal / mechanistic evidence

The pediatric rationale follows gonadotropin activity on testicular endocrine development under specialist care.[1][5]

Testicular function during TRT or AAS suppression

Injectable

56%Emerging

TRT or AAS suppression support is distinct from the unsupported Simeons hCG diet claim and should stay focused on testicular volume, spermatogenesis, and clinician-managed fertility goals.[4][2][11][3]

Human evidence

Male hypogonadism and infertility literature discusses hCG-based approaches for preserving or restoring testicular function in testosterone-suppressed contexts, including TRT and anabolic-androgenic-steroid suppression discussions.[4][2][11][3]

Animal / mechanistic evidence

The mechanism is maintenance of intratesticular LH-like signaling when endogenous gonadotropins are suppressed.[4][2][11][3]

Evidence snapshot

82%

Human evidence

Strong

FDA labeling and reproductive-medicine practice support injectable hCG for specific fertility goals.[1][2][3][4]

34%

Animal / preclinical

Limited

LH/CG receptor activation directly supports ovulation-trigger and gonadal-axis physiology.[1][2][3][4]

82%

Mechanism support

Strong

hCG activates LH/CG receptors in ovaries and testes. It can trigger final oocyte maturation/ovulation or stimulate testicular testosterone production when the axis is responsive.[1][2][3][4]

Forms & administration

Human chorionic gonadotropin comes in urinary-hCG powder vials and the recombinant prefilled syringe Ovidrel. Strength, units and fertility timing depend on the product and indication. Sublingual preparations and intrauterine administration remain separate investigational contexts, with their own preparation requirements.[22][17][20][21][35]

InjectableSublingualIntrauterine

Dosing & protocols

These ranges are general reference points, not personal dosing instructions.

Typical Range

Common male endocrine protocols start at 500-1,000 IU per dose. Other uses require different doses.[22]

Frequency

Male endocrine protocols commonly use 3 injections per week.[22]

Timing Considerations

Timing depends on the treatment goal and lab monitoring.[22][17]

Cycle Length

A common starting phase lasts 3 weeks, followed by a lower-frequency phase.[22]

What to expect

Same day

Injectable hCG ovulation-trigger use is cycle-timed, with the expected reproductive effect tied to follicle response and clinic confirmation.[1][2][3][4][17]

Weeks to months

Injectable male reproductive-axis protocols may show changes in testosterone, estradiol, testicular response, semen parameters, and symptoms.[1][2][3][4][17]

After stopping

Testosterone and fertility markers may drift toward baseline after injectable hCG stops if the underlying axis problem remains.[1][2][3][4][17]

Safety profile

hCG safety is reproductive-endocrine and indication-specific: injection reactions, headache, mood symptoms, edema, OHSS, gynecomastia, thromboembolism, and sports status matter.[1][2][3][19]

Common side effects

Cautions

What we don't know

Non-medical weight-loss, performance, and casual hormone-support use have different risk-benefit profiles from reproductive care.[1][2][3][19]

Who hCG is not for

Route-specific avoid and medical-review notes:

  • Pregnancy unless part of supervised reproductive care

    Pregnancy unless part of supervised reproductive care warrants medical review or avoidance for hCG.[1][2][3]

  • Hormone-sensitive cancer without specialist review

    Hormone-sensitive cancer without specialist review warrants medical review or avoidance for hCG.[1][2][3]

  • Unexplained uterine bleeding or ovarian cysts without clinician review

    Unexplained uterine bleeding or ovarian cyst without clinician review warrants medical review or avoidance for hCG.[1][2][3]

Drug & supplement interactions

Documented interactions are separated from theoretical or route-specific cautions.

Theoretical interactions

  • Gonadotropins / fertility meds

    FSH, LH, clomiphene, letrozole, or multi-drug fertility protocols can compound ovarian-stimulation and multiple-gestation risk; this is a route-specific reproductive caution.[1][2][3][19]

  • Testosterone / estrogen modulators

    Testosterone, SERMs, aromatase inhibitors, or estrogen therapy can change testosterone-estradiol response and gynecomastia signals; this is a theoretical pathway caution.[1][2][3][19]

  • Diuretics during OHSS risk

    Diuretics can worsen the intravascular-volume problem in OHSS contexts; this is a route-specific caution.[1][2][3][19]

  • Performance stacks

    Performance stacks that combine hCG with androgens or masking strategies add endocrine and anti-doping risk; this is a theoretical pathway caution.[1][2][3][19]

How it works

hCG activates LH/CG receptors in ovaries and testes. In plain terms, injectable hCG can trigger final oocyte maturation or ovulation in fertility care, and it can stimulate testicular testosterone production when Leydig cells remain responsive.[1][2][3][4]

Because hCG acts downstream at the gonad, the mechanism is different from kisspeptin or gonadorelin. Sex, dose, fertility goal, estrogen response, ovarian status, testicular status, and monitoring determine whether the hormone signal is useful or risky. The injectable route also makes ovarian hyperstimulation and androgen effects practical concerns.[1][2][3][4]

Research gaps & open questions

What the current literature has not yet settled about hCG:

01

Research and public guidance need to clearly separate hCG's established reproductive uses from unsupported diet, weight-loss, and performance claims.[1][2][3][4]

02

Long-term comparisons should show how well hCG preserves sperm production and testicular function relative to other fertility strategies in men receiving testosterone or recovering from it.[1][2][3][4]

03

Studies of individual hCG products need to show which regimens, if any, safely restore fertility or hormone function after anabolic steroids or prescribed testosterone.[1][2][3][4]

Common questions

Is hCG FDA-approved?

Yes. hCG products have FDA-approved reproductive-endocrine indications in the U.S., including specific fertility and hypogonadism contexts.[17][18][1]

Is hCG approved for weight loss?

No. hCG is not FDA-approved for weight loss; weight-loss claims are separate from reproductive-endocrine indications.[17][18][1]

Is hCG the same as gonadorelin?

No. hCG acts at LH/CG receptors downstream; gonadorelin is GnRH upstream at the pituitary.[17][18][1]

Myths & misconceptions

Myth

The hCG diet is an approved hormone protocol.

Reality

hCG approval is reproductive-endocrine, not a weight-loss approval.[1][2][3][4]

Myth

hCG is a simple testosterone booster.

Reality

It changes reproductive hormones and needs lab-guided monitoring.[1][2][3][4]

History & discovery

hCG became a clinical reproductive hormone because its LH-like activity can act directly at gonadal receptors. Its history is fertility and endocrine medicine before wellness or diet-market claims. That distinction keeps the origin story tied to evidence strength, route, and product identity rather than broad clinical certainty.[1][2][3][4]

Injectable hCG became useful for ovulation triggering and reproductive-endocrine contexts because it can mimic LH activity. That established a supervised, indication-specific route history.[1][2][3][4]

Later literature reviewed male hypogonadism and infertility use, while weight-loss and performance claims diverged from labeling. The history therefore separates legitimate endocrine use from misuse.[1][2][3][4]

Published research35 citations

Show citationsHide citations

PepFlow library coverage

Keep It Organized

Make time for your personal well-being goals.

Use PepFlow to record your hCG protocol, set reminders for your own schedule, and review your history.

Download on the App StoreGet it on Google Play
PepFlow calendar on Thursday, April 9, listing BPC-157 at 10:00 and GHK-CU at 18:00